Clinical trial NCT03349463 - References

Cervical Cancer — Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.

Citation(s)

•   Atri M, Zhang Z, Dehdashti F, Lee SI, Ali S, Marques H, Koh WJ, Moore K, Landrum L, Kim JW, DiSilvestro P, Eisenhauer E, Schnell F, Gold M
  Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial. Gynecol Oncol. 2016 Sep;142(3):413-9. doi: 10.1016/j.ygyno.2016.05.002. Epub 2016 Jul 27.
•   Cannistra SA
  Cancer of the ovary. N Engl J Med. 2004 Dec 9;351(24):2519-29. Review. Erratum in: N Engl J Med. 2005 Jan 6;352(1):104.
•   Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA
  Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med. 2001 Mar;42(3):432-45. Review.
•   Khiewvan B, Torigian DA, Emamzadehfard S, Paydary K, Salavati A, Houshmand S, Shamchi SP, Werner TJ, Aydin A, Roy SG, Alavi A, Kumar R
  Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer. Hell J Nucl Med. 2016 Sep-Dec;19(3):254-268. doi: 10.1967/s002449910409. Epub 2016 Nov 8. Review.
•   Kim TH, Kim J, Kang YK, Lee M, Kim HS, Cheon GJ, Chung HH
  Identification of Metabolic Biomarkers Using Serial (18)F-FDG PET/CT for Prediction of Recurrence in Advanced Epithelial Ovarian Cancer. Transl Oncol. 2017 Jun;10(3):297-303. doi: 10.1016/j.tranon.2017.02.001. Epub 2017 Mar 15.
•   Kizer NT, Zighelboim I, Case AS, Dewdney SB, Thaker PH, Massad LS
  The role of PET/CT in the management of patients with cervical cancer: practice patterns of the members of the Society of Gynecologic Oncologists. Gynecol Oncol. 2009 Aug;114(2):310-4. doi: 10.1016/j.ygyno.2009.04.018. Epub 2009 May 14.
•   Rockall AG, Cross S, Flanagan S, Moore E, Avril N
  The role of FDG-PET/CT in gynaecological cancers. Cancer Imaging. 2012 Mar 5;12:49-65. doi: 10.1102/1470-7330.2012.0007. Review.
•   Signorelli M, Guerra L, Buda A, Picchio M, Mangili G, Dell'Anna T, Sironi S, Messa C
  Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases. Gynecol Oncol. 2009 Nov;115(2):231-5. doi: 10.1016/j.ygyno.2009.07.020. Epub 2009 Aug 19.
•   Washburn LC, Sun TT, Anon JB, Hayes RL
  Effect of structure on tumor specificity of alicyclic alpha-amino acids. Cancer Res. 1978 Aug;38(8):2271-3.
•   Washburn LC, Sun TT, Byrd B, Hayes RL, Butler TA
  1-aminocyclobutane[11C]carboxylic acid, a potential tumor-seeking agent. J Nucl Med. 1979 Oct;20(10):1055-61.

Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. Pilot Study.

Details for clinical trial NCT03349463